HRP20080350T3 - Preparation of somatostatin peptides - Google Patents
Preparation of somatostatin peptidesInfo
- Publication number
- HRP20080350T3 HRP20080350T3 HR20080350T HRP20080350T HRP20080350T3 HR P20080350 T3 HRP20080350 T3 HR P20080350T3 HR 20080350 T HR20080350 T HR 20080350T HR P20080350 T HRP20080350 T HR P20080350T HR P20080350 T3 HRP20080350 T3 HR P20080350T3
- Authority
- HR
- Croatia
- Prior art keywords
- alkylene
- formula
- protecting group
- preparation
- independently
- Prior art date
Links
- 102000005157 Somatostatin Human genes 0.000 title 1
- 108010056088 Somatostatin Proteins 0.000 title 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 4
- 125000006239 protecting group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical class C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0318682.2A GB0318682D0 (en) | 2003-08-08 | 2003-08-08 | Organic compounds |
| PCT/EP2004/008850 WO2005014624A2 (en) | 2003-08-08 | 2004-08-06 | Preparation of somatostatin peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20080350T3 true HRP20080350T3 (en) | 2008-08-31 |
Family
ID=27839906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20080350T HRP20080350T3 (en) | 2003-08-08 | 2008-07-15 | Preparation of somatostatin peptides |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US7615609B2 (xx) |
| EP (1) | EP1654280B8 (xx) |
| JP (1) | JP4580928B2 (xx) |
| KR (1) | KR101136633B1 (xx) |
| CN (2) | CN1832962A (xx) |
| AR (1) | AR045327A1 (xx) |
| AT (1) | ATE394424T1 (xx) |
| AU (1) | AU2004262570B2 (xx) |
| BR (1) | BRPI0413437B1 (xx) |
| CA (1) | CA2534224C (xx) |
| CO (1) | CO5660271A2 (xx) |
| CY (1) | CY1108775T1 (xx) |
| DE (1) | DE602004013599D1 (xx) |
| DK (1) | DK1654280T3 (xx) |
| EC (1) | ECSP066352A (xx) |
| ES (1) | ES2307039T3 (xx) |
| GB (1) | GB0318682D0 (xx) |
| HK (1) | HK1090065A1 (xx) |
| HR (1) | HRP20080350T3 (xx) |
| IL (1) | IL173272A (xx) |
| IS (1) | IS2894B (xx) |
| MA (1) | MA27982A1 (xx) |
| MX (1) | MXPA06001525A (xx) |
| MY (1) | MY141731A (xx) |
| NO (1) | NO338367B1 (xx) |
| NZ (1) | NZ544961A (xx) |
| PE (2) | PE20091210A1 (xx) |
| PL (1) | PL1654280T3 (xx) |
| PT (1) | PT1654280E (xx) |
| RU (1) | RU2360921C2 (xx) |
| SI (1) | SI1654280T1 (xx) |
| TN (1) | TNSN06045A1 (xx) |
| TW (1) | TWI345570B (xx) |
| WO (1) | WO2005014624A2 (xx) |
| ZA (1) | ZA200600584B (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5331817B2 (ja) | 2007-12-03 | 2013-10-30 | イタルファルマコ ソシエタ ペル アチオニ | 新規な非選択的ソマトスタチン類似体 |
| EP2067786A1 (en) | 2007-12-07 | 2009-06-10 | ITALFARMACO S.p.A. | Novel non selective analogs of somatostatin |
| DK2343051T3 (da) | 2010-01-05 | 2014-10-27 | Nat Univ Dong Hwa | Anti-cancer formulering |
| CN103467575B (zh) * | 2013-08-22 | 2016-03-02 | 深圳翰宇药业股份有限公司 | 一种帕西瑞肽的制备方法 |
| CN103641894B (zh) * | 2013-12-06 | 2015-10-28 | 深圳翰宇药业股份有限公司 | 一种治疗库欣病的多肽药物的制备方法 |
| EP3233899B1 (en) * | 2014-12-19 | 2020-06-24 | Auro Peptides LTD | A process for the preparation of pasireotide |
| CN106188231B (zh) * | 2015-05-25 | 2021-10-22 | 中国医学科学院药物研究所 | 帕西瑞肽五肽中间体的合成与应用 |
| CN114621326B (zh) * | 2020-12-10 | 2023-12-26 | 武汉武药科技有限公司 | 门冬氨酸帕瑞肽及其中间体和其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3303345A1 (de) | 1983-02-02 | 1984-08-02 | Hoechst Ag, 6230 Frankfurt | Cyclische peptide mit somatostatin-wirkung |
| EP0255224A3 (en) | 1986-06-30 | 1990-04-18 | Merck & Co. Inc. | Cyclic and bridged cyclic somatostatin analogs useful as analgesic agents |
| US5811512A (en) | 1991-08-22 | 1998-09-22 | The Trustees Of The University Of Pennsylvania | Non-peptide peptidomimetics and related cyclic hexapeptides |
| EP0720621B1 (en) | 1993-06-23 | 2001-02-07 | Diatide, Inc. | Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |
| US5770687A (en) | 1995-06-07 | 1998-06-23 | Peptor Limited | Comformationally constrained backbone cyclized somatostatin analogs |
| US6355613B1 (en) | 1996-07-31 | 2002-03-12 | Peptor Limited | Conformationally constrained backbone cyclized somatostatin analogs |
| GB0018891D0 (en) * | 2000-08-01 | 2000-09-20 | Novartis Ag | Organic compounds |
-
2003
- 2003-08-08 GB GBGB0318682.2A patent/GB0318682D0/en not_active Ceased
-
2004
- 2004-08-03 MY MYPI20043138A patent/MY141731A/en unknown
- 2004-08-05 AR ARP040102788A patent/AR045327A1/es not_active Application Discontinuation
- 2004-08-06 KR KR1020067002613A patent/KR101136633B1/ko active Protection Beyond IP Right Term
- 2004-08-06 PT PT04763881T patent/PT1654280E/pt unknown
- 2004-08-06 MX MXPA06001525A patent/MXPA06001525A/es active IP Right Grant
- 2004-08-06 BR BRPI0413437-0A patent/BRPI0413437B1/pt not_active IP Right Cessation
- 2004-08-06 RU RU2006106721/04A patent/RU2360921C2/ru active
- 2004-08-06 CN CNA2004800227946A patent/CN1832962A/zh active Pending
- 2004-08-06 EP EP04763881A patent/EP1654280B8/en active Active
- 2004-08-06 PE PE2008001723A patent/PE20091210A1/es not_active Application Discontinuation
- 2004-08-06 AT AT04763881T patent/ATE394424T1/de active
- 2004-08-06 CA CA2534224A patent/CA2534224C/en active Active
- 2004-08-06 PE PE2004000764A patent/PE20050356A1/es not_active Application Discontinuation
- 2004-08-06 AU AU2004262570A patent/AU2004262570B2/en active Active
- 2004-08-06 PL PL04763881T patent/PL1654280T3/pl unknown
- 2004-08-06 DK DK04763881T patent/DK1654280T3/da active
- 2004-08-06 NZ NZ544961A patent/NZ544961A/en not_active IP Right Cessation
- 2004-08-06 CN CN2010105957529A patent/CN102127155B/zh active Active
- 2004-08-06 US US10/567,299 patent/US7615609B2/en active Active
- 2004-08-06 DE DE602004013599T patent/DE602004013599D1/de active Active
- 2004-08-06 WO PCT/EP2004/008850 patent/WO2005014624A2/en active IP Right Grant
- 2004-08-06 SI SI200430804T patent/SI1654280T1/sl unknown
- 2004-08-06 TW TW093123701A patent/TWI345570B/zh not_active IP Right Cessation
- 2004-08-06 JP JP2006522331A patent/JP4580928B2/ja active Active
- 2004-08-06 ES ES04763881T patent/ES2307039T3/es active Active
-
2006
- 2006-01-19 IL IL173272A patent/IL173272A/en active IP Right Grant
- 2006-01-20 ZA ZA2006/00584A patent/ZA200600584B/en unknown
- 2006-02-07 MA MA28779A patent/MA27982A1/fr unknown
- 2006-02-07 EC EC2006006352A patent/ECSP066352A/es unknown
- 2006-02-07 TN TNP2006000045A patent/TNSN06045A1/en unknown
- 2006-03-02 IS IS8338A patent/IS2894B/is unknown
- 2006-03-02 CO CO06020917A patent/CO5660271A2/es active IP Right Grant
- 2006-03-08 NO NO20061125A patent/NO338367B1/no unknown
- 2006-09-20 HK HK06110468A patent/HK1090065A1/xx unknown
-
2008
- 2008-07-15 HR HR20080350T patent/HRP20080350T3/xx unknown
- 2008-08-06 CY CY20081100823T patent/CY1108775T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20080350T3 (en) | Preparation of somatostatin peptides | |
| MY130830A (en) | Inhibitors | |
| CA2318579A1 (en) | Nitrogen-containing heterocyclic compounds and medicaments containing the compounds | |
| TW200724136A (en) | Pharmaceutical compositions comprising PPAR modulator | |
| RS49586B (sr) | Derivati supstituisane 4-hidroksi-fenilalkanske kiseline sa dejstvom agonista na ppar-gama | |
| ATE401319T1 (de) | Substituierte 2-(2,6-dioxopiperidin-3-yl)- phthalimide und verfahren zur verminderung des tnf-alpha spiegels | |
| WO2003080580A3 (en) | Quinoline derivatives and their use as 5-ht6 ligands | |
| WO2003039451A3 (en) | Thiazole pyridazinones as adenosine antagonists | |
| AU6116698A (en) | Amine compounds, their production and use as amyloid-beta production inhibitors | |
| MEP25608A (en) | Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics | |
| HRP20050390A2 (en) | Substituted benzoxazinones and uses thereof | |
| ES2162466T3 (es) | Derivados de 1,2,4-triazolo(4,3-b)pirido(3,2-d)piridazina y composiciones farmaceuticas que los contienen. | |
| TNSN03045A1 (en) | QUINAZOLINES AS MMP-13 INHIBITORS | |
| DK0615978T3 (da) | Peptidderivater af borsyre med proteaseinhiberende virkning, fremgangsmåde til fremstilling heraf samt farmaceutiske sammen | |
| ATE60605T1 (de) | 7-substituierte bicyclische pyrazolidinone. | |
| HRP20010193B1 (en) | Synergistic active substance combinations for controlling harmful plants | |
| RO112859B1 (ro) | Derivaţi de amide de aminoacizi, procedee pentru prepararea acestora şi compoziţii fungicide care îi conţin | |
| AP9901695A0 (en) | Quinoline-4-carbaoxamide derivatives as NK-2 and NK-3 receptor antagonists. | |
| RS20050806A (xx) | 4-supstituisani hinolin derivati,metod i intermedijeri za njihovo dobijanje i farmaceutski oblici koji ih sadrže | |
| DE68926981D1 (de) | Cephemverbindungen und Verfahren zu ihrer Herstellung | |
| GB9825554D0 (en) | Novel Compounds | |
| HRP20090158T1 (en) | Substituted pyrroles, compositions containing same, method for making same and use thereof | |
| EP1375496A4 (en) | N-ARYL SUBSTITUTED CYCLIC AMINE DERIVATIVE AND MEDICAMENT CONTAINING SAID DERIVATIVE AS ACTIVE INGREDIENT | |
| MEP12108A (en) | Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them | |
| KR950701329A (ko) | 벤조티아졸술폰아미드 유도체, 그의 제조법 및 그 용도(Benzothiazolesulfornamide derivative, method for preparing the same, and use thereof) |